ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

330
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
30 Jan 2021 05:58

Asia Short Interest: BYD, Smoore, GCL Poly, Olympus, Nomura, Anritsu, Netmarble, UMC, Innolux, Acer

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
297 Views
Share
20 Jan 2021 01:36

JY Lee & The Ides of March.....and What It Means for You

The impact of the JY Lee jail sentencing and what it means for Samsung Electronics, Samsung C&T and its affiliates  down the line.

Logo
302 Views
Share
bullishSamsung C&T
15 Jan 2021 01:46

Samsung C&T: Valuation Sensitivity Analysis & Key Catalysts

We provide an updated valuation of Samsung C&T and key catalysts of the company. Our base case valuation of Samsung C&T is implied price of 231,387...

Logo
453 Views
Share
14 Jan 2021 19:04

Innovent Biologics Placement - Momentum Is Very Strong but past Deals Have Been Mixed

Innovent Biologics Inc (1801 HK) is looking to raise about U$600m to fund its clinical trials  and product licensing and possible M&A. This will be...

Logo
429 Views
Share
12 Jan 2021 18:52

Ocumension Theraputics Placement - IPO Was Hot, Deal Should Be Supported Despite Lock-Up Expiry

Ocumension Therapeutics (1477 HK) aims to raise around US$103m to commercialize new products, fund clinical trials and develop new facilities.

Logo
285 Views
Share
x